Laidlaw Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $698K | Sell |
895
-1
| -0.1% | -$780 | 2.01% | 16 |
|
|
2025
Q1 | $740K | Sell |
896
-982
| -52% | -$811K | 2.18% | 14 |
|
|
2024
Q4 | $1.45M | Buy |
1,878
+149
| +9% | +$115K | 0.63% | 43 |
|
|
2024
Q3 | $1.53M | Buy |
1,729
+343
| +25% | +$304K | 0.76% | 40 |
|
|
2024
Q2 | $1.25M | Sell |
1,386
-12
| -0.9% | -$10.9K | 0.69% | 45 |
|
|
2024
Q1 | $1.09M | Sell |
1,398
-1,379
| -50% | -$1.07M | 0.61% | 51 |
|
|
2023
Q4 | $1.62M | Buy |
2,777
+289
| +12% | +$168K | 0.59% | 42 |
|
|
2023
Q3 | $1.34M | Sell |
2,488
-220
| -8% | -$118K | 0.44% | 66 |
|
|
2023
Q2 | $1.27M | Sell |
2,708
-1,247
| -32% | -$585K | 0.25% | 99 |
|
|
2023
Q1 | $1.36M | Buy |
3,955
+446
| +13% | +$153K | 0.28% | 97 |
|
|
2022
Q4 | $1.28M | Buy |
3,509
+1,453
| +71% | +$532K | 0.28% | 100 |
|
|
2022
Q3 | $665K | Buy |
2,056
+465
| +29% | +$150K | 0.16% | 148 |
|
|
2022
Q2 | $516K | Sell |
1,591
-643
| -29% | -$209K | 0.11% | 195 |
|
|
2022
Q1 | $640K | Buy |
2,234
+1,169
| +110% | +$335K | 0.11% | 187 |
|
|
2021
Q4 | $294K | Buy |
+1,065
| New | +$294K | 0.05% | 312 |
|